- Filed
- Feb 18, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 14, 2025 | 99.11M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2024 | 99.86M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2024 | 9.14M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 5.74M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 5.55M sh |
| Operating Cash Flow | Q2 2025 · Oct 31, 2024 | −$505.86K |
| Operating Cash Flow restated | Q2 2025 · Oct 31, 2023 | −$628.88K |
| Stockholders Equity | Q2 2025 · Oct 31, 2024 | −$2.92M |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | −$2.22M |
| Stockholders Equity | Q2 2025 · Apr 30, 2024 | −$1.99M |
| Stockholders Equity restated | Q2 2025 · Oct 31, 2023 | $1.54M |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $1.89M |
| Stockholders Equity restated | Q2 2025 · Apr 30, 2023 | $2.21M |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $3.25M |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $2.54M |
| Current Assets | Q2 2025 · Oct 31, 2024 | $128.25K |
| Current Assets | Q2 2025 · Apr 30, 2024 | $153.83K |
| Total Assets | Q2 2025 · Oct 31, 2024 | $329.67K |
| Total Assets | Q2 2025 · Apr 30, 2024 | $548.56K |
| Eps Diluted | Q2 2025 · Oct 31, 2024 | −$0.01 |
| Eps Diluted | Q2 2025 · Oct 31, 2024 | −$0.01 |
| Eps Diluted restated | Q2 2025 · Oct 31, 2023 | −$0.06 |
| Eps Diluted restated | Q2 2025 · Oct 31, 2023 | −$0.12 |
| Eps Basic | Q2 2025 · Oct 31, 2024 | −$0.01 |
| Eps Basic | Q2 2025 · Oct 31, 2024 | −$0.01 |
| Eps Basic restated | Q2 2025 · Oct 31, 2023 | −$0.06 |
| Eps Basic restated | Q2 2025 · Oct 31, 2023 | −$0.12 |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $341.87K |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $841.39K |
| Sga Expense restated | Q2 2025 · Oct 31, 2023 | $191.85K |
| Sga Expense restated | Q2 2025 · Oct 31, 2023 | $349.48K |
| Net Income | Q2 2025 · Oct 31, 2024 | −$1.02M |
| Net Income | Q2 2025 · Oct 31, 2024 | −$727.62K |
| Net Income restated | Q2 2025 · Oct 31, 2023 | −$331.91K |
| Net Income restated | Q2 2025 · Oct 31, 2023 | −$648.71K |
| Operating Income | Q2 2025 · Oct 31, 2024 | −$995.51K |
| Operating Income | Q2 2025 · Oct 31, 2024 | −$1.69M |
| Operating Income restated | Q2 2025 · Oct 31, 2023 | −$303.33K |
| Operating Income restated | Q2 2025 · Oct 31, 2023 | −$630.28K |
| Revenue | Q2 2025 · Oct 31, 2024 | $87.28K |
| Revenue | Q2 2025 · Oct 31, 2024 | $123.42K |
| Revenue restated | Q2 2025 · Oct 31, 2023 | $59.5K |
| Revenue restated | Q2 2025 · Oct 31, 2023 | $135.19K |